Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
AbstractOcular posterior segment diseases such as uveitis, X-linked juvenile retinoschisis, or age-related macular degeneration usually result in progressive and irreversible vision loss. Although intravitreal injection is the main way to deliver drugs to the posterior eye, it still has shortcomings...
Main Authors: | Hui Jiang, Zhuping Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2023.2204206 |
Similar Items
-
Lipid Nanoparticles for the Posterior Eye Segment
by: Lorena Bonilla, et al.
Published: (2021-12-01) -
Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye
by: Cheng-Han Tsai, et al.
Published: (2022-06-01) -
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment
by: Andrea Gabai, et al.
Published: (2023-07-01) -
5-Flurouracil microencapsulation and impregnation in hyaluronic acid hydrogel as composite drug delivery system for ocular fibrosis
by: Meghali Bora, et al.
Published: (2016-12-01) -
Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution
by: Laura Gisela González Iglesias, et al.
Published: (2022-08-01)